IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q1 2023 Holdings

Filed 2023-05-15 | 3 holdings | $72.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$40.1M2,936,50755.6%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$32.1M3,846,15444.4%
Viracta Therapeutics IncCOM92765F108$5.9K3,7000.0%